EKI-785

N/A

Report date: 2022/05/05 11:11:32

Base Information

Drug NameEKI-785
Drug Alias NameEKI-785
ClassificationOther
Mechanisms of ActionEpidermal growth factor inhibitors
TargetsEpidermal growth factor
Therapy Area/IndicationsPolycystic Kidney, Autosomal Recessive
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesWyeth Holdings LLC
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesWyeth Holdings LLC
Active IndicationsN/A
Inactive IndicationsPolycystic Kidney, Autosomal Recessive

Other Information

ATC CodeN/A
Related LinksN/A